Orfamide B (C09-0996-126)

Aladdin

Catalog No.: C09-0996-126
Manufacturer No.: O329289-1mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $343.16

List Price: $381.29

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Orfamide B is a component of a family of cyclic lipopeptides produced by|Pseudomonas fluorescens|, reported in 2007. The orfamides were discovered by employing genomic analysis with an isotope-guided fractionation to identify metabolites produced by orphan gene clusters containing non-ribosomal peptide synthetases. Orfamide B has not been further investigated, although its activity is thought to parallel that of orfamide A and other cyclic lipopeptides produced by Pseudomonas. Molecular Formula: C63H112N10O17 Molecular Weight: 1281.62 PubChem CID: 137699707 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/O329289-SCI_d7a29b8051602124cf7dea6cf0a93f52.pdf

UPC:: 12352211
Condition:: New
Availability:: 8-12 weeks
Weight:: 0.96 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: O329289-1mg
CAS:: 939960-35-7
Product Size:: 1mg
Precautionary Statement Codes:: P264

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."